Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INSTASPON is an Indian medical device company specializing in the manufacture of absorbable gelatin sponges used for rapid hemostasis during surgical procedures. The company's flagship product, INSTASPON, is a sterile, water-insoluble, and biocompatible sponge derived from purified gelatin that facilitates blood clotting by forming a mechanical matrix. These sponges are used across various surgical specialties, including dental, neurosurgery, and orthopedic surgery, and are designed to be fully absorbed by the body within 4 to 6 weeks. INSTASPON also provides bulk semi-finished products and OEM manufacturing services for global distributors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INSTASPON.